Literature DB >> 19219675

A first report of radioembolization for hepatic metastases from ocular melanoma.

Andrew S Kennedy1, Charles Nutting, Tobias Jakobs, Roberto Cianni, Ermanno Notarianni, Amos Ofer, Alex Beny, William A Dezarn.   

Abstract

BACKGROUND: Ocular melanoma (OM) metastasizes to the liver and is rapidly fatal despite aggressive therapy. Yttrium-90 microspheres (radioembolization) delivered via the hepatic artery is an established and effective approach for primary and metastatic hepatic tumors, although (90)Y use in OM has not been reported previously.
METHODS: A retrospective review was performed for all patients with OM who received radioembolization at 5 centers.
RESULTS: 11 patients received 12 treatments with a median activity of 1.55 GBq delivered per treatment. Toxicity was minimal, with PET/CT at 3 months posttreatment showing a response in all patients; 1 patient had a complete response.
CONCLUSIONS: Radioembolization can control hepatic metastases of OM with very few side effects.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19219675     DOI: 10.1080/07357900802620893

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  16 in total

1.  90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: a pilot study.

Authors:  Nicholas Fidelman; Robert K Kerlan; Randall A Hawkins; Andrew G Taylor; Maureen P Kohi; K Pallav Kolli; Emily K Bergsland; R Kate Kelley; Andrew H Ko; W Michael Korn; Ryan M McWhirter; Jennifer Luan; Alan P Venook
Journal:  J Gastrointest Cancer       Date:  2014-06

2.  Yttrium-90 Microsphere Brachytherapy for Liver Metastases From Uveal Melanoma: Clinical Outcomes and the Predictive Value of Fluorodeoxyglucose Positron Emission Tomography.

Authors:  Harriet Eldredge-Hindy; Nitin Ohri; Pramila R Anne; David Eschelman; Carin Gonsalves; Charles Intenzo; Voichita Bar-Ad; Adam Dicker; Laura Doyle; Jun Li; Takami Sato
Journal:  Am J Clin Oncol       Date:  2016-04       Impact factor: 2.339

Review 3.  Locoregional Therapies for the Treatment of Uveal Melanoma Hepatic Metastases.

Authors:  Carin F Gonsalves; Robert D Adamo; David J Eschelman
Journal:  Semin Intervent Radiol       Date:  2020-12-11       Impact factor: 1.513

4.  A pilot study of intrahepatic yttrium-90 microsphere radioembolization in combination with intravenous cisplatin for uveal melanoma liver-only metastases.

Authors:  Surein Arulananda; Sagun Parakh; Jodie Palmer; Mark Goodwin; Miles C Andrews; Jonathan Cebon
Journal:  Cancer Rep (Hoboken)       Date:  2019-05-14

5.  Reduction of Nodular Growth Pattern of Metastatic Uveal Melanoma after Radioembolization of Hepatic Metastases.

Authors:  Kevin M Halenda; Ragini R Kudchadkar; David H Lawson; Darren D Kies; Kristen E Zhelnin; Alyssa M Krasinskas; Hans E Grossniklaus
Journal:  Ocul Oncol Pathol       Date:  2015-12-24

6.  A Prospective Phase II Trial of Radioembolization for Treatment of Uveal Melanoma Hepatic Metastasis.

Authors:  Carin F Gonsalves; David J Eschelman; Robert D Adamo; P Rani Anne; Marlana M Orloff; Mizue Terai; Anthony N Hage; Misung Yi; Inna Chervoneva; Takami Sato
Journal:  Radiology       Date:  2019-08-27       Impact factor: 11.105

7.  Hepatic artery infusion of melphalan in patients with liver metastases from ocular melanoma.

Authors:  Brian A Boone; Samantha Perkins; Rupal Bandi; Ernesto Santos; Kevin McCluskey; David L Bartlett; James F Pingpank
Journal:  J Surg Oncol       Date:  2018-04       Impact factor: 3.454

Review 8.  Transhepatic therapies for metastatic uveal melanoma.

Authors:  David J Eschelman; Carin F Gonsalves; Takami Sato
Journal:  Semin Intervent Radiol       Date:  2013-03       Impact factor: 1.513

Review 9.  Effects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumors.

Authors:  Andrew Kuei; Sammy Saab; Sung-Ki Cho; Stephen T Kee; Edward Wolfgang Lee
Journal:  World J Gastroenterol       Date:  2015-07-21       Impact factor: 5.742

Review 10.  Isolated hepatic perfusion for patients with liver metastases.

Authors:  Srinevas K Reddy; Susan B Kesmodel; H Richard Alexander
Journal:  Ther Adv Med Oncol       Date:  2014-07       Impact factor: 8.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.